Oral Formulation of Angiotensin-(1–7) Improves Lipid Metabolism and Prevents High-Fat Diet–Induced Hepatic Steatosis and Inflammation in Mice-Reference-Cited by-同舟云学术

Oral Formulation of Angiotensin-(1–7) Improves Lipid Metabolism and Prevents High-Fat Diet–Induced Hepatic Steatosis and Inflammation in Mice

Published:2013-08 Issue:2 Volume:62 Page:324-330
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Feltenberger John David¹,Andrade João Marcus Oliveira¹,Paraíso Alanna¹,Barros Lucas Oliveira¹,Filho Aristides Batista Maia¹,Sinisterra Ruben D.M.¹,Sousa Frederico B.¹,Guimarães André Luiz Sena¹,de Paula Alfredo Mauricio Batista¹,Campagnole-Santos Maria José¹,Qureshi Mahboob¹,dos Santos Robson Augusto Souza¹,Santos Sérgio Henrique Sousa¹

Affiliation:

1. From the Laboratory of Health Science, Postgraduate Program in Health Sciences, Universidade Estadual de Montes Claros, Montes Claros, MG, Brazil (J.D.F., J.M.O.A., A.P., L.O.B., A.B.M.F., A.L.S.G, A.M.B.d.P., S.H.S.S.); Department of Pharmacology, Institute of Biological Sciences (S.H.S.S.) and National Institute of Science and Technology in Nanobiopharmaceutics (R.D.M.S., F.B.S., M.J.C.-S., R.A.S.d.S.), Universidade Federal de Minas Gerais, Minas Gerais, Belo Horizonte, Brazil; and Medical School,...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference47 articles.

1. Obesity

2. Obesity, inflammation, and atherosclerosis

3. Obesity, Inflammation, and Insulin Resistance

4. Obesity Affects the Liver – The Link between Adipocytes and Hepatocytes

5. Inflammation and metabolic disorders

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dietary supplementation with black cricket (Gryllus assimilis) reverses protein-energy malnutrition and modulates renin-angiotensin system expression in adipose tissue;Food Research International;2024-08

2. Overexpression of the Mas1 gene mitigated LPS-induced inflammatory injury in mammary epithelial cells by inhibiting the NF-κB/MAPKs signaling pathways;Frontiers in Veterinary Science;2024-07-12

3. Review of current and new drugs for the treatment of metabolic-associated fatty liver disease;Hepatology International;2024-06-08

4. Gut–Kidney–Heart: A Novel Trilogy;Biomedicines;2023-11-15

5. Mas receptor: a potential strategy in the management of ischemic cardiovascular diseases;Cell Cycle;2023-06-26